Audio Recap, Click Here. Gambia updated its Guideline for Clinical Trials in Humans, effective February 26. This change impacts multiple regulatory areas including aggregate safety reports, clinical trials, and post-marketing ICSR reporting. iViReg users received the validated alert on March 3, with full updates reflected in the Gambia Country Profile by March 10.
